Blueprint Medicines Highlights Clinical Progress Across Precision Oncology Pipeline at 2023 ASCO Annual Meeting
“At ASCO, we are reporting early clinical data for three [...]
Innovent Updates Phase 1b Data of IBI939 (Anti-TIGIT Monoclonal Antibody) Combined with Sintilimab in Previously Untreated PD-L1-selected NSCLC at the 2023 ASCO Annual Meeting
The company updated the Phase 1b efficacy and safety results [...]
Pangaea Data Awarded Strategic Partnership by Mersey Care NHS Foundation Trust and the University of Liverpool’s Mental Health Research for Innovation Centre (M-RIC)
Dr. Vibhor Gupta, Founder and Director at Pangaea, said: “We [...]
Omeros Completes Sale of OMIDRIA® Franchise to Rayner Surgical
Omeros received approximately $126 million in cash at closing. In [...]